Stem Cell and Cancer Institute   Report issue

Academic/Hospital Phase 1
Founded: East Jakarta Indonesia (2006)

Organization Overview

First Clinical Trial
2019
NCT04134676
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Stem Cell and Cancer Institute, Kalbe Farma Tbk

Active Ingredients

Drugs in Phase 1 Trials (1)

mupirocin (bactroban) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1